Keros Therapeutics said on Wednesday it would voluntarily halt testing of its experimental blood pressure treatment due to safety concerns during a mid-stage trial. Its shares fell 8% to $11.52 in ...

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...

Nighttime aircraft noise exacerbates health issues by disturbing sleep and recovery, contributing to structural changes in ...

Bringing a child into the world can be a joyous occasion, but for many moms their birthing experience can be a fight for ...

It looks like that Apple is going to have a busy 2025. There are a number of devices coming from the company, including the ...